Analysts expect Regentis Biomaterials Ltd. to report revenue of 0.00 for 2026, against a range of 0.00 to 0.00. The most recent reported year, 2025, came in at 0.00.
| Metric | 2025 | 2026 |
|---|---|---|
| Reported (Actual) | 0.00 | - |
| High Estimate | - | 0.00 |
| Low Estimate | - | 0.00 |
| Consensus Estimate | - | 0.00 |
Analysts expect Regentis Biomaterials Ltd. to report earnings per share of -0.63 for 2026, against a range of -0.66 to -0.60. The most recent reported year, 2025, came in at -24.16.
| Metric | 2025 | 2026 |
|---|---|---|
| Reported (Actual) | -24.16 | - |
| High Estimate | - | -0.60 |
| Low Estimate | - | -0.66 |
| Consensus Estimate | - | -0.63 |
Pull Wall Street consensus for Regentis Biomaterials Ltd. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=RGNT&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "RGNT", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=RGNT&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();